The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration. [electronic resource]
- BMC ophthalmology Nov 2018
- 298 p. digital
Publication Type: Journal Article
1471-2415
10.1186/s12886-018-0960-6 doi
Aged Aged, 80 and over Angiogenesis Inhibitors--therapeutic use Biomarkers Female Humans Macular Degeneration--drug therapy Male Middle Aged Prevalence Ranibizumab--therapeutic use Receptors, Vascular Endothelial Growth Factor--therapeutic use Recombinant Fusion Proteins--therapeutic use Retina--pathology Retreatment Retrospective Studies Visual Acuity